New camera for prostate cancer bone radiation
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a special camera (VERITON-CT) to help guide precise radiation for bone tumors that have spread from prostate cancer. It may improve targeting accuracy during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have prostate cancer that has spread to your bones
- Your doctor has recommended bone radiation (stereotactic radiotherapy)
- You are in good general health (able to care for yourself)
- You have health insurance (social security)
- You have not had radiation to the same bone area before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of scanning cameras to see how well they record images in people with thyroid cancer treated with iodine 131. It may help improve which camera gives clearer results after this treatment.
This study tests whether a specialized nuclear imaging camera can better detect multiple tumors or lesions in your body. You'll receive a standard radioactive tracer scan (like a bone scan or thyroid scan) that's already part of your care, but we'll also image you with this newer camera technology to see if it works well.
This trial tests a new radiation technique to better protect erectile function during prostate cancer treatment. It uses advanced imaging to precisely target the tumor while reducing harm to nearby structures.
This trial looks at whether a precise form of radiation (stereotactic body radiotherapy) can control a small number of prostate cancer spots seen on a special scan (PSMA PET/CT). It may help by treating limited metastases while avoiding unnecessary treatment elsewhere.
This study tests a precise type of radiation (stereotactic radiotherapy) for men with early-stage prostate cancer. It aims to see if using custom radiation beams improves outcomes while reducing side effects.
This trial uses a special imaging scan (SPECT/CT) with a small amount of radioactive tracer to look at prostate cancer. It aims to see how well the scan matches your prostate cancer tests and may help improve detection and assessment.
Hear when a new Prostatic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.